Download Free Sample
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Hematology Diagnostics Market: By Testing Product, By Test Type, By End User, and Geography
Hematology Diagnostics Market: By Testing Product, By Test Type, By End User, and Geography
| 1. Executive Summary |
| 2. Global Hematology Diagnostics Market Introduction |
| 2.1. Global Hematology Diagnostics Market – Taxonomy |
| 2.2. Global Hematology Diagnostics Market –Definitions |
| 2.2.1. By Testing Product |
| 2.2.2. By Test Type |
| 2.2.3. By End User |
| 2.2.4. By Region |
| 3. Global Hematology Diagnostics Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Hematology Diagnostics Market Dynamic Factors - Impact Analysis |
| 3.6. Global Hematology Diagnostics Market – Competition Landscape |
| 4. Global Hematology Diagnostics Market Analysis,2017-2021 and Forecast, 2022-2028 |
| 4.1. Market Analysis,2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Hematology Diagnostics Market, By Testing Product, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 5.1. Instruments |
| 5.1.1. Fully Automated Analyzers |
| 5.1.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.1.3. Market Opportunity Analysis |
| 5.1.2. Semi-Automated Analyzers |
| 5.1.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.2.3. Market Opportunity Analysis |
| 5.1.3. Flow cytometers |
| 5.1.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 5.1.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3.3. Market Opportunity Analysis |
| 5.1.4. Others |
| 5.1.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 5.1.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.4.3. Market Opportunity Analysis |
| 5.2. Consumables |
| 5.2.1. Reagents |
| 5.2.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 5.2.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.1.3. Market Opportunity Analysis |
| 5.2.2. Stains |
| 5.2.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 5.2.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.2.3. Market Opportunity Analysis |
| 5.2.3. Controls & Calibrators |
| 5.2.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 5.2.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3.3. Market Opportunity Analysis |
| 5.2.4. Others |
| 5.2.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 5.2.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.4.3. Market Opportunity Analysis |
| 6. Global Hematology Diagnostics Market Forecast, By Test Type, 2017-2021 and Forecast, 2021 – 2027 (Revenue, US$ Mn) |
| 6.1. Blood count |
| 6.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Platelet function & Clotting |
| 6.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Hemoglobin |
| 6.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Hematocrit |
| 6.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Bone Marrow Biopsy |
| 6.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. global Hematology Diagnostics Market, By End User, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 7.1. Hospital |
| 7.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Diagnostic labs |
| 7.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Global Hematology Diagnostics Market Forecast, By Region, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia-Pacific |
| 8.3.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Latin America |
| 8.4.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 8.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Middle East and Africa |
| 8.5.1. Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 8.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 8.6. Global Hematology Diagnostics Market - Opportunity Analysis Index, By Testing Product, Test Type, End User, and Region, 2022-2028 |
| 9. North America Hematology Diagnostics market analysis,2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 9.1. By Testing Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1. Instruments |
| 9.1.1.1. Fully Automated Analyzers |
| 9.1.1.2. Semi-Automated Analyzers |
| 9.1.1.3. Flow cytometers |
| 9.1.1.4. Others |
| 9.1.2. Consumables |
| 9.1.2.1. Reagents |
| 9.1.2.2. Stains |
| 9.1.2.3. Controls & Calibrators |
| 9.1.2.4. Others |
| 9.2. Test Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1. Blood count |
| 9.2.2. Platelet function & Clotting |
| 9.2.3. Hemoglobin |
| 9.2.4. Hematocrit |
| 9.2.5. Bone Marrow Biopsy |
| 9.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1. Hospital |
| 9.3.2. Diagnostic labs |
| 9.3.3. Others |
| 9.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1. USA |
| 9.4.2. Canada |
| 9.5. North America Hematology Diagnostics Market - Opportunity Analysis Index, By Testing Product, Test Type, End User, and Country, 2022-2028 |
| 9.6. North America Hematology Diagnostics Market Dynamics – Trends |
| 10. Europe Hematology Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 10.1. By Testing Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Instruments |
| 10.1.1.1. Fully Automated Analyzers |
| 10.1.1.2. Semi-Automated Analyzers |
| 10.1.1.3. Flow cytometers |
| 10.1.1.4. Others |
| 10.1.2. Consumables |
| 10.1.2.1. Reagents |
| 10.1.2.2. Stains |
| 10.1.2.3. Controls & Calibrators |
| 10.1.2.4. Others |
| 10.2. Test Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Blood count |
| 10.2.2. Platelet function & Clotting |
| 10.2.3. Hemoglobin |
| 10.2.4. Hematocrit |
| 10.2.5. Bone Marrow Biopsy |
| 10.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Hospital |
| 10.3.2. Diagnostic labs |
| 10.3.3. Others |
| 10.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Germany |
| 10.4.2. UK |
| 10.4.3. France |
| 10.4.4. Spain |
| 10.4.5. Italy |
| 10.4.6. Russia |
| 10.4.7. Poland |
| 10.4.8. Rest of Europe |
| 10.5. Europe Hematology Diagnostics Market - Opportunity Analysis Index, By Testing Product, Test Type, End User, and Country, 2022-2028 |
| 10.6. Europe Hematology Diagnostics Market Dynamics – Trends |
| 11. Asia-Pacific Hematology Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 11.1. By Testing Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Instruments |
| 11.1.1.1. Fully Automated Analyzers |
| 11.1.1.2. Semi-Automated Analyzers |
| 11.1.1.3. Flow cytometers |
| 11.1.1.4. Others |
| 11.1.2. Consumables |
| 11.1.2.1. Reagents |
| 11.1.2.2. Stains |
| 11.1.2.3. Controls & Calibrators |
| 11.1.2.4. Others |
| 11.2. Test Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1. Blood count |
| 11.2.2. Platelet function & Clotting |
| 11.2.3. Hemoglobin |
| 11.2.4. Hematocrit |
| 11.2.5. Bone Marrow Biopsy |
| 11.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1. Hospital |
| 11.3.2. Diagnostic labs |
| 11.3.3. Others |
| 11.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1. Japan |
| 11.4.2. China |
| 11.4.3. India |
| 11.4.4. ASEAN |
| 11.4.5. Australia & New Zealand |
| 11.4.6. Rest of Asia-Pacific |
| 11.5. Asia-Pacific Hematology Diagnostics Market - Opportunity Analysis Index, By Testing Product, Test Type, End User, and Country, 2022-2028 |
| 11.6. Asia-Pacific Hematology Diagnostics Market Dynamics – Trends |
| 12. Latin America Hematology Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 12.1. By Testing Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Instruments |
| 12.1.1.1. Fully Automated Analyzers |
| 12.1.1.2. Semi-Automated Analyzers |
| 12.1.1.3. Flow cytometers |
| 12.1.1.4. Others |
| 12.1.2. Consumables |
| 12.1.2.1. Reagents |
| 12.1.2.2. Stains |
| 12.1.2.3. Controls & Calibrators |
| 12.1.2.4. Others |
| 12.2. Test Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1. Blood count |
| 12.2.2. Platelet function & Clotting |
| 12.2.3. Hemoglobin |
| 12.2.4. Hematocrit |
| 12.2.5. Bone Marrow Biopsy |
| 12.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1. Hospital |
| 12.3.2. Diagnostic labs |
| 12.3.3. Others |
| 12.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Brazil |
| 12.4.2. Mexico |
| 12.4.3. Argentina |
| 12.4.4. Rest of Latin America |
| 12.5. Latin America Hematology Diagnostics Market - Opportunity Analysis Index, By Testing Product, Test Type, End User, and Country, 2022-2028 |
| 12.6. Latin America Hematology Diagnostics Market Dynamics – Trends |
| 13. Middle East and Africa Hematology Diagnostics Market Analysis, 2017-2021 and Forecast, 2022-2028 (Revenue, US$ Mn) |
| 13.1. By Testing Product Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Instruments |
| 13.1.1.1. Fully Automated Analyzers |
| 13.1.1.2. Semi-Automated Analyzers |
| 13.1.1.3. Flow cytometers |
| 13.1.1.4. Others |
| 13.1.2. Consumables |
| 13.1.2.1. Reagents |
| 13.1.2.2. Stains |
| 13.1.2.3. Controls & Calibrators |
| 13.1.2.4. Others |
| 13.2. Test Type Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.2.1. Blood count |
| 13.2.2. Platelet function & Clotting |
| 13.2.3. Hemoglobin |
| 13.2.4. Hematocrit |
| 13.2.5. Bone Marrow Biopsy |
| 13.3. End User Analysis 2017-2021 and Forecast 2022-2028 by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Hospital |
| 13.3.2. Diagnostic labs |
| 13.3.3. Others |
| 13.4. Country Analysis 2017-2021 and Forecast 2022-2028by Revenue (US$ Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Gulf Cooperation Council (GCC) Countries |
| 13.4.2. Israel |
| 13.4.3. South Africa |
| 13.4.4. Rest of MEA |
| 13.5. MEA Hematology Diagnostics Market - Opportunity Analysis Index, By Testing Product, Test Type, End User, and Country, 2022-2028 |
| 13.6. MEA Hematology Diagnostics Market Dynamics – Trends |
| 14. Competition Landscape |
| 14.1. Strategic Dashboard of Top Market Players |
| 14.2. Company Profiles (Introduction, Financial Analysis, Test Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 14.2.1. Sysmex |
| 14.2.2. Danaher |
| 14.2.3. Nihon Kohden |
| 14.2.4. Siemens |
| 14.2.5. Abbott Laboratories |
| 14.2.6. Boule Diagnostics |
| 14.2.7. HORIBA |
| 14.2.8. Bio-Rad Laboratories |
| 14.2.9. BioSystems |
| 14.2.10. Diatron |
| 14.2.11. Roche |
| 15. Research Methodology |
| 16. Key Assumptions and Acronyms |
Latin America
Europe
Asia Pacific
Middle East
North America
Download Free Sample Report
2021 is the base year and 2028 is the forecast year.
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
Key Market Players
Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthcare domain, encompassing pharmaceuticals, medical devices, and diagnostics. A graduate in Pharmacy, he possesses a strong foundation in the intricacies of the healthcare sector. He further enhanced his expertise by pursuing an MBA in Pharmaceuticals, equipping him with valuable business acumen. His analytical skills and market insights have contributed to strategic decision-making and enhanced market positioning for various healthcare organizations. Committed to driving innovation and excellence, Muni continues to seek opportunities to improve healthcare delivery through data-driven insights.